News about product and service launches
MENLO PARK, Calif., Sept. 14, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB), a leading provider of high-quality sequencing of genomes, transcriptomes, and epigenomes, today announced the appointment of Susan G. Kim as Chief Financial Officer, effective as of September 28, 2020.“I am delighted that Susan is joining the company at a... Read more
75% of patients with relapsing-remitting multiple sclerosis (RRMS) and suboptimal response to prior treatment had no evidence of disease activity two years after switching to OCREVUS in open-label Phase IIIb CASTING study 97% persistence and strong adherence to OCREVUS treatment and twice-yearly dosing schedule from real-world data OCREVUS is the first and only treatment approved... Read more
ENSPRYNG lowered relapse severity in double-blind periods of SAkura Phase III studies. Pooled data from SAkura open-label extension (OLE) studies support continued effect of ENSPRYNG reducing risk of relapse in the longer term Ongoing data continues to show a favourable safety profile for ENSPRYNG ENSPRYNG was recently approved by the U.S. Food and Drug Administration... Read more
Caption: RiboShield™ RNase Inhibitor. Click images to download. London, UK (09 September 2020) — PCR Biosystems has today launched RiboShield™ RNase Inhibitor. Already an important component of several PCR Biosystems kits, this robust and reliable RNase inhibitor is, for the first time, available as a standalone product. RiboShield™ RNase Inhibitor is a recombinant protein that blocks the activity of a... Read more
Thermo Fisher Scientific Opens New Bioprocessing Collaboration Center in St. Louis Combines bioproduction and pharma services to accelerate innovation in biologics manufacturing WALTHAM, Mass., Sept. 9, 2020 /PRNewswire/ — Thermo Fisher Scientific Inc., the world leader in serving science, today announced the opening of its new Bioprocessing Collaboration Center (BCC) in St. Louis, Missouri. The facility... Read more
New data further reinforce OCREVUS (ocrelizumab) as a highly effective treatment option offering a favourable and consistent benefit:risk profile, with high treatment persistence and adherence Initiation of Phase IIIb OCREVUS higher dose clinical trial programme and Phase IV study evaluating OCREVUS in minority populations Initiation of Phase III clinical trial programme for fenebrutinib, an investigational... Read more
Sep 1, 2020 Nikon Instruments Inc. is pleased to announce the release of NIS-Elements Clarify.ai, a new addition to Nikon’s growing suite of artificial intelligence (AI) tools for microscopy. Clarify.ai uses artificial intelligence to automatically remove blur from widefield fluorescence microscope images. Clarify.ai utilizes new Nikon technologies executed on graphic processing units (GPUs) to leverage fast... Read more
Thermo Fisher Scientific Officially Opens New Site for Manufacturing COVID-19 Sample Collection Products New facility in Lenexa, Kansas built in six weeks to rapidly expand production of viral transport media LENEXA, Kan., Aug. 28, 2020 /PRNewswire/ — Thermo Fisher Scientific Inc., the world leader in serving science, officially cut the ribbon on its new $40 million facility in... Read more
Kits detect traces of SARS-CoV-2 virus on surfaces such as plastics, ceramics and stainless steel WHAT: PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today introduced two COVID-19 environmental testing kits to help food processors and contract labs detect the presence of SARS-CoV-2 on surfaces in food plants such as plastic, ceramic... Read more
Venlo, The Netherlands, August 21, 2020 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced today a transition in the leadership of its Supervisory Board after an extraordinary meeting of the Supervisory Board and Managing Board. Lawrence A. Rosen, a member of the QIAGEN Supervisory Board since 2013, was appointed by the Supervisory Board as the... Read more